ReviewCureus2022

Efficacy and Safety of Insulin Degludec/Insulin Aspart (IDegAsp) in Type 2 Diabetes: Systematic Review and Meta-Analysis.

Brenda C Edina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.